Japan Medical Dynamic Marketing (FRA:JMD) ROCE %: 1.50% (As of Mar. 2026)

What is Japan Medical Dynamic Marketing ROCE %?

Japan Medical Dynamic Marketing FRA:JMD +2.89% 77 ROCE % is 1.50% as of Mar. 2026. GuruFocus rates FRA:JMD with a GF Score™ of 77/100 and a GF Value™ of €3.39. The stock has 12 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Japan Medical Dynamic Marketing's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.50%.

Japan Medical Dynamic Marketing (FRA:JMD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Japan Medical Dynamic Marketing ROCE % Related Terms

Japan Medical Dynamic Marketing ROCE % Historical Data

* Premium members only.

The historical data trend for Japan Medical Dynamic Marketing's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Medical Dynamic Marketing ROCE % Chart

Japan Medical Dynamic Marketing Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

11.83

6.80

5.87

-1.00

2.39

Japan Medical Dynamic Marketing Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-21.43	2.08	0.87	5.54	1.50

77GF Score

Japan Medical Dynamic Marketing Inc FRA:JMD

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Japan Medical Dynamic Marketing ROCE % Calculation

Japan Medical Dynamic Marketing's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	3.785	/	( ( (208.927 - 45.043)	+	(194.491 - 42.039) )	/ 2 )
	=	3.785	/	( (163.884	+	152.452)	/ 2 )
	=	3.785	/	158.168
	=	2.39 %

Japan Medical Dynamic Marketing's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	2.288	/	( ( (188.828 - 36.62)	+	(194.491 - 42.039) )	/ 2 )
	=	2.288	/	( ( 152.208	+	152.452 )	/ 2 )
	=	2.288	/	152.33
	=	1.50 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 1.50% mean?

Japan Medical Dynamic Marketing (FRA:JMD) has a ROCE % of 1.50% as of Mar. 2026.

Is Japan Medical Dynamic Marketing's ROCE % too high?

Japan Medical Dynamic Marketing's current ROCE % is 1.50%. The Medical Devices & Instruments industry median ROCE % is 2.23. Japan Medical Dynamic Marketing's value of 1.50% is 32.7% below this industry median. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.

How does Japan Medical Dynamic Marketing's ROCE % compare to ABT and SYK?

Japan Medical Dynamic Marketing's ROCE % of 1.50% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Japan Medical Dynamic Marketing's value of 1.50% is 32.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Medical Dynamic Marketing's current ROCE % of 1.50% is 32.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Medical Dynamic Marketing's current ROCE % is 1.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Japan Medical Dynamic Marketing stock overvalued right now?

Japan Medical Dynamic Marketing (FRA:JMD) has a current ROCE % of 1.50%. The stock's GF Value™ is €3.39, compared to a current price of €4.98 — trading 46.9% above its estimated fair value. The current ROCE % is 1.50% and 32.7% below the Medical Devices & Instruments industry median of 2.23. Japan Medical Dynamic Marketing's overall GF Score™ is 77/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (FRA:JMD), the current ROCE % is 1.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Medical Dynamic Marketing (FRA:JMD) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued. The current stock price of €4.98 is trading 46.9% above its estimated GF Value™ of €3.39.

Key valuation signals for FRA:JMD:

ROCE %: 1.50%
GF Value™: €3.39 vs. price of €4.98 (46.9% above fair value)
GF Score™: 77/100 with 12 warning signs
Industry Position: 32.7% below the Medical Devices & Instruments median

No single metric tells the full story. See the FRA:JMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Japan Medical Dynamic Marketing Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TSE:4889 TSE:6678 TSE:7792 TSE:3079 TSE:9341 TSE:5187 TSE:7963 TSE:7707 TSE:4890 TSE:4548 ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges JMDMF:USA 7600:Japan

Address 12-2, Ichigayadaimachi, Shinjuku-ku, Tokyo, JPN, 162-0066

Website http://www.jmdm.co.jp

Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.

77GF Score

Get the complete analysis for FRA:JMD

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.98

Price

€3.39

GF Value

View FRA:JMD Analysis

See ROCE % data for all stocks →